Stellate cells and the development of liver cancer: Therapeutic potential of targeting the stroma

Journal of Hepatology

Volumn 60, Issue 6, 2014, Pages 1306-1309

  Coulouarn, Cédric ^a   Clément, Bruno ^b  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Fibrosis; Genomics; Hepatic stellate cell; Liver cancer; Microenvironment; Therapeutics

Indexed keywords

B RAF KINASE; BEVACIZUMAB; BIOLOGICAL MARKER; CETUXIMAB; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 22; INTERLEUKIN 6; K RAS PROTEIN; KALININ; LY 2109761; MICRORNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NOTCH RECEPTOR; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR; RANTES; SONIC HEDGEHOG PROTEIN; SORAFENIB; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; TRICHOSTATIN A; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ADVANCED CANCER; ANGIOGENESIS; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER PROGNOSIS; CELL ACTIVATION; CELL AGING; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; FIBROGENESIS; FUNCTIONAL GENOMICS; GENE EXPRESSION PROFILING; IMMUNOCOMPETENT CELL; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FIBROSIS; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; STELLATE CELL; STROMA CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; BILE DUCT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; HUMAN; INTRAHEPATIC BILE DUCT; LIVER NEOPLASMS; PATHOLOGY; CANCER GROWTH; CANCER STAGING; CELL POLARITY; MICROENVIRONMENT; NONHUMAN; PATHOGENESIS; TARGET CELL; TUMOR CELL;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; HEPATIC STELLATE CELLS; HUMANS; LIVER NEOPLASMS; STROMAL CELLS; TUMOR MICROENVIRONMENT;

EID: 84901203792     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.02.003     Document Type: Note

References (25)

1. D. Hanahan, and L.M. Coussens Accessories to the crime: functions of cells recruited to the tumor microenvironment Cancer Cell 21 2012 309 322
2. N.A. Bhowmick, E.G. Neilson, and H.L. Moses Stromal fibroblasts in cancer initiation and progression Nature 432 2004 332 337
3. M.R. Junttila, and F.J. de Sauvage Influence of tumour micro-environment heterogeneity on therapeutic response Nature 501 2013 346 354
4. V. Hernandez-Gea, S. Toffanin, S.L. Friedman, and J.M. Llovet Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma Gastroenterology 144 2013 512 527
5. S.L. Friedman Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver Physiol Rev 88 2008 125 172
6. A.E. Place, S. Jin Huh, and K. Polyak The microenvironment in breast cancer progression: biology and implications for treatment Breast Cancer Res 13 2011 227
7. A. Budhu, M. Forgues, Q.H. Ye, H.L. Jia, P. He, and K.A. Zanetti et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment Cancer Cell 10 2006 99 111
8. J.B. Andersen, and S.S. Thorgeirsson Genetic profiling of intrahepatic cholangiocarcinoma Curr Opin Gastroenterol 28 2012 266 272
9. L. Sulpice, M. Rayar, M. Desille, B. Turlin, A. Fautrel, and E. Boucher et al. Molecular profiling of stroma identifies Osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma Hepatology 58 2013 1992 2000
10. D.X. Cao, Z.J. Li, X.O. Jiang, Y.L. Lum, E. Khin, and N.P. Lee et al. Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers World J Gastroenterol 18 2012 3923 3930
11. C. Coulouarn, V.M. Factor, and S.S. Thorgeirsson Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer Hepatology 47 2008 2059 2067
12. C. Coulouarn, C. Cavard, L. Rubbia-Brandt, A. Audebourg, F. Dumont, and S. Jacques et al. Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways Carcinogenesis 33 2012 1791 1796
13. S. De Minicis, E. Seki, H. Uchinami, J. Kluwe, Y. Zhang, and D.A. Brenner et al. Gene expression profiles during hepatic stellate cell activation in culture and in vivo Gastroenterology 132 2007 1937 1946
14. Y. Chen, S.S. Choi, G.A. Michelotti, I.S. Chan, M. Swiderska-Syn, and G.F. Karaca et al. Hedgehog controls hepatic stellate cell fate by regulating metabolism Gastroenterology 143 2012 1319 1329
15. T. Luedde, and R.F. Schwabe NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma Nat Rev Gastroenterol Hepatol 8 2011 108 118
16. N. Kang, G.J. Gores, and V.H. Shah Hepatic stellate cells: partners in crime for liver metastases? Hepatology 54 2011 707 713
17. A. Santamato, E. Fransvea, F. Dituri, A. Caligiuri, M. Quaranta, and T. Niimi et al. Hepatic stellate cells stimulate HCC cell migration via laminin-5 production Clin Sci (Lond) 121 2011 159 168
18. D.H. Dapito, A. Mencin, G.Y. Gwak, J.P. Pradere, M.K. Jang, and I. Mederacke et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4 Cancer Cell 21 2012 504 516
19. C. Coulouarn, A. Corlu, D. Glaise, I. Guénon, S.S. Thorgeirsson, and B. Clément Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma Cancer Res 72 2012 2533 2542
20. M. Mikula, V. Proell, A.N. Fischer, and W. Mikulits Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-beta dependent fashion J Cell Physiol 209 2006 560 567
21. A. Gentilini, K. Rombouts, S. Galastri, A. Caligiuri, E. Mingarelli, and T. Mello et al. Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma J Hepatol 57 2012 813 820
22. A. Mallat, and S. Lotersztajn Cellular mechanisms of tissue fibrosis 5. Novel insights into liver fibrosis Am J Physiol Cell Physiol 305 2013 C789 C799
23. Y. Wang, J. Gao, D. Zhang, J. Zhang, J. Ma, and H. Jiang New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis J Hepatol 53 2010 132 144
24. L. Hammerich, J.M. Bangen, O. Govaere, H.W. Zimmermann, N. Gassler, and S. Huss et al. Chemokine receptor CCR6-dependent accumulation of γδ T-cells in injured liver restricts hepatic inflammation and fibrosis Hepatology 59 2014 630 642
25. G. Giannelli, A. Mazzocca, E. Fransvea, M. Lahn, and S. Antonaci Inhibiting TGF-β signaling in hepatocellular carcinoma Biochim Biophys Acta 1815 2011 214 223